Drawing for EMULATE THERAPEUTICS

USPTO serial 97389517

EMULATE THERAPEUTICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GAYNOR, BARBARA ANNE
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EMULATE THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus for use in treating cancer, pain, inflammation, and solid cancer tumors such as mycosis fungoides, plasma cell tumors, fibrosarcomas, neurofibrosarcomas, schwannomas, malignant melanomas, hermangiopericytomas, hepatic adenocarcinomas, mast cell tumors, mammary adenocarcinomas, osteosarcomas, chondrosarcomas, apocrine glandadenocarcinomas, undifferentiated carcinomas, and transitional cell carcinomas tumors, and mental health conditions, namely, PTSD, depression, anxiety and addiction; Medical device for treating cancerABANDONED—
042Product development in the field of medical device technology; Research and development in the field of medical device technology for use in treating cancer, pain, inflammation, tumors, and a wide range of ailments and disease; Research and development of technology in the field of disease treatmentABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 15, 2024MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Feb 14, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Feb 14, 2024OP.SOPPOSITION SUSTAINED NO. 999999—
Feb 14, 2024ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Nov 15, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 11, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2023PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 7, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 7, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 7, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2023ALIEASSIGNED TO LIE—
Feb 17, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2023DOCKASSIGNED TO EXAMINER—
May 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 3, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance